| 摘要 |
<p><P>PROBLEM TO BE SOLVED: To provide an ocular disease remedy suitable for protection and treatment of the nerve cell of the retina in ocular diseases. <P>SOLUTION: Administration of the pituitary adenylate cyclase-activating polypeptide (PACAP) promotes production of the endogenous physiologically active factor IL-6, or interleukin 6, in the main glia cell of the retina (neuroglia cell), or the Muller cell, and thereby enables indirect inhibition and retardation of the cell death of the retinal ganglion cell (RGC: retinal ganglion cell) forming the optic nerve. <P>COPYRIGHT: (C)2007,JPO&INPIT</p> |
